These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Growth inhibition and induction of apoptosis in MCF-7 breast cancer cells by oridonin nanosuspension. Feng FF; Zhang DR; Tian KL; Lou HY; Qi XL; Wang YC; Duan CX; Jia LJ; Wang FH; Liu Y; Zhang Q Drug Deliv; 2011 May; 18(4):265-71. PubMed ID: 21091387 [TBL] [Abstract][Full Text] [Related]
4. Studies on pharmacokinetics and tissue distribution of oridonin nanosuspensions. Gao L; Zhang D; Chen M; Duan C; Dai W; Jia L; Zhao W Int J Pharm; 2008 May; 355(1-2):321-7. PubMed ID: 18242896 [TBL] [Abstract][Full Text] [Related]
5. In vitro antitumor activity of silybin nanosuspension in PC-3 cells. Zheng D; Wang Y; Zhang D; Liu Z; Duan C; Jia L; Wang F; Liu Y; Liu G; Hao L; Zhang Q Cancer Lett; 2011 Aug; 307(2):158-64. PubMed ID: 21507570 [TBL] [Abstract][Full Text] [Related]
6. Emodin loaded solid lipid nanoparticles: preparation, characterization and antitumor activity studies. Wang S; Chen T; Chen R; Hu Y; Chen M; Wang Y Int J Pharm; 2012 Jul; 430(1-2):238-46. PubMed ID: 22465546 [TBL] [Abstract][Full Text] [Related]
7. Oridonin-loaded poly(epsilon-caprolactone)-poly(ethylene oxide)-poly(epsilon-caprolactone) copolymer nanoparticles: preparation, characterization, and antitumor activity on mice with transplanted hepatoma. Feng N; Wu P; Li Q; Mei Y; Shi S; Yu J; Xu J; Liu Y; Wang Y J Drug Target; 2008 Jul; 16(6):479-85. PubMed ID: 18604660 [TBL] [Abstract][Full Text] [Related]
8. An HPLC method for determination of oridonin in rabbits using isopsoralen as an internal standard and its application to pharmacokinetic studies for oridonin-loaded nanoparticles. Mei Y; Xu J; Zhao J; Feng N; Liu Y; Wei L J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Jun; 869(1-2):138-41. PubMed ID: 18514594 [TBL] [Abstract][Full Text] [Related]
9. In vivo studies on the oridonin-loaded nanostructured lipid carriers. Zheng D; Dai W; Zhang D; Duan C; Jia L; Liu Y; Zhang Q Drug Deliv; 2012 Aug; 19(6):286-91. PubMed ID: 22928767 [TBL] [Abstract][Full Text] [Related]
10. [Regulation of telomerase activity and cell cycle of K562 cells by oridonin]. Li RF; Wang QD Yao Xue Xue Bao; 2004 Nov; 39(11):865-8. PubMed ID: 15696923 [TBL] [Abstract][Full Text] [Related]
11. Synergistic effect of oridonin and cisplatin on cytotoxicity and DNA cross-link against mouse sarcoma S180 cells in culture. Gao ZG; Ye QX; Zhang TM Zhongguo Yao Li Xue Bao; 1993 Nov; 14(6):561-4. PubMed ID: 8010060 [TBL] [Abstract][Full Text] [Related]
12. Preparation and characterization of an oridonin nanosuspension for solubility and dissolution velocity enhancement. Gao L; Zhang D; Chen M; Zheng T; Wang S Drug Dev Ind Pharm; 2007 Dec; 33(12):1332-9. PubMed ID: 18097807 [TBL] [Abstract][Full Text] [Related]
13. Galactosylated chitosan nanoparticles for hepatocyte-targeted delivery of oridonin. Zheng D; Duan C; Zhang D; Jia L; Liu G; Liu Y; Wang F; Li C; Guo H; Zhang Q Int J Pharm; 2012 Oct; 436(1-2):379-86. PubMed ID: 22732673 [TBL] [Abstract][Full Text] [Related]
14. The anti-tumor effect of folate-targeted liposome microbubbles loaded with oridonin as ultrasound-triggered tumor-targeted therapeutic carrier system. Wang C; Li W; Hu B J Drug Target; 2017 Jan; 25(1):83-91. PubMed ID: 27282800 [TBL] [Abstract][Full Text] [Related]
15. Effects of oridonin nanosuspension on cell proliferation and apoptosis of human prostatic carcinoma PC-3 cell line. Zhang Z; Zhang X; Xue W; Yangyang Y; Xu D; Zhao Y; Lou H Int J Nanomedicine; 2010 Oct; 5():735-42. PubMed ID: 21042419 [TBL] [Abstract][Full Text] [Related]
16. Actinomycin D inhibiting K562 cell apoptosis elicited by salvicine but not decreasing its cytotoxicity. Qing C; Miao ZH; Tong LJ; Zhang JS; Ding J Acta Pharmacol Sin; 2003 May; 24(5):415-21. PubMed ID: 12740176 [TBL] [Abstract][Full Text] [Related]
17. [The tissue distribution in mice and pharmacokinetics in rabbits of oridonin-solid lipid nanoparticles]. Zhang DR; Ren TC; Lou HX; Xing J Yao Xue Xue Bao; 2005 Jun; 40(6):573-6. PubMed ID: 16144328 [TBL] [Abstract][Full Text] [Related]
18. Oridonin inhibits the proliferation of human osteosarcoma cells by suppressing Wnt/β-catenin signaling. Liu Y; Liu YZ; Zhang RX; Wang X; Meng ZJ; Huang J; Wu K; Luo JY; Zuo GW; Chen L; Yin LJ; Deng ZL; He BC Int J Oncol; 2014 Aug; 45(2):795-803. PubMed ID: 24859848 [TBL] [Abstract][Full Text] [Related]
19. In vitro and in vivo anticancer activity of a novel puerarin nanosuspension against colon cancer, with high efficacy and low toxicity. Wang Y; Ma Y; Zheng Y; Song J; Yang X; Bi C; Zhang D; Zhang Q Int J Pharm; 2013 Jan; 441(1-2):728-35. PubMed ID: 23089583 [TBL] [Abstract][Full Text] [Related]
20. Downregulation of AP-1 gene expression is an initial event in the oridonin-mediated inhibition of colorectal cancer: studies in vitro and in vivo. Jin H; Tan X; Liu X; Ding Y J Gastroenterol Hepatol; 2011 Apr; 26(4):706-15. PubMed ID: 21418301 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]